GenoScreen
From 26 to 28 march 2019
ContaminExpo, Paris, FRANCE
Meet us at ContaminExpo, in Paris Porte de Versaille, FRANCE, from 26 to 28 march 2019.
December 18th, 2018
4th Adebiotech Campus, at Romainville-Grand Paris
Meet us at the 4th Adebiotech Campus, on December 18th, 2018 at Biocitech Romainville-Grand Paris.
From 4th to 5th december 2018
Biofit, Lille, France
You can meet us on the 4th and the 5th December 2018 at the 7th edition of BioFIT who take place at Lille Grand Palais.
From 27th to 30th november 2018
Pollutec 2018, Lyon, France
Meet us at Pollutec Lyon, the 28th November 2018 for the conclusion of the BioDISSPOL project, co-financed by ADEME.
March 14-15 2018
Pharmabiotics 2018
On Thursday, March 15, Stephanie Ferreira, Director of Development, will participate in the round table entitled "Panel Discussion: How to Overcome the Difficulties Relating to the Inter-Analysis Variability" at Pharmabiotics 2018 in Paris. She will talk at the session "Bioinformatics Challenges in Microbiome Analysis" at 4 pm.
CNHU
OMS
Subcategories
Partners
GenoScreen develops its technologies and know-how in genomics within a dense, well-structured network of partners.
These collaborations co-fund ambitious research programs and jointly develop innovative technologies: an effective and agile strategy that opens up new opportunities for our staff.
Collaborative research - At the heart of international innovation in genomics
GenoScreen is a partner in collaborative research projects that bring together startups, multinationals and public-sector organizations. Our R&D teams provide their knowledge and expertise in the molecular microbiology of isolated agents and complex communities. This allowed our teams to develop our own projects for elaborating innovative products and services.
Our projects are designed to:
- Improve the diagnosis and management of acute/chronic diseases on humans and animals,
- Characterize and monitor microbial biodiversity, with applications in agronomy, agrifood and environment.
The common feature of these projects is the development of molecular tools for the characterization, monitoring and diagnosis of microbial communities. The key objective is to market simple analytical solutions and (ultimately) preventive, corrective or even therapeutic products based on microorganisms.